Skip to main content

Table 2 Allelic genotypes and frequency in male controls and cases

From: Short rare hTERT-VNTR2-2nd alleles are associated with prostate cancer susceptibility and influence gene expression

Genotype

Male controls

421 [N(%)]

Prostate cancer

329 [N(%)]

OR (95% CI)

P

28/44

0 (0.00)

1 (0.30)

-

0.2576

37/44

0 (0.00)

1 (0.30)

-

0.2576

39/42

1 (0.24)

1 (0.30)

1.28 (0.08-20.5)

0.8611

39/44

0 (0.00)

3 (0.91)

-

0.0496*

40/42

0 (0.00)

1 (0.30)

-

0.2576

40/44

1 (0.24)

1 (0.30)

1.28 (0.08-20.5)

0.8611

42/42

54 (12.83)

37 (11.25)

0.86 (0.55-1.34)

0.5107

42/43

6 (1.43)

6 (1.82)

1.28 (0.41-4.02)

0.6660

42/44

192 (45.61)

150 (45.59)

1.00 (0.75-1.34)

0.9972

43/44

15 (3.56)

7 (2.13)

0.59 (0.24-1.46)

0.2477

44/44

152 (36.10)

121 (36.79)

1.03 (.076-1.39)

0.8491

C/C

419 (99.52)

321 (97.57)

5.22 (1.10-24.76)

C/R

2 (0.48)

8 (2.43)

P = 0.02*

  1. Bold numbers represent the rare alleles of hTERT-VNTR2-2nd. C, common alleles; R, rare alleles. * Statistically significant (P < 0.05)